提高软组织肉瘤的认识:患者与医疗保健工作者讨论的播客
1Patient Advocate, Aberdeen Sarcoma Support Group, Aberdeen, Aberdeenshire, Scotland.
Oncology and therapy
|May 13, 2025
概括
诊断罕见的软组织肉瘤 (结缔组织癌症) 是一个挑战. 本播客由一名患者和一名护士共同讨论了肉瘤的诊断,治疗和影响,强调了专业护理的必要性.
科学领域:
- 在瘤学瘤学.
- 医学教育 医学教育
背景情况:
- 软组织肉瘤是一种罕见的癌症 (<1%的新诊断),有80多种亚型,经常模仿其他疾病.
- 诊断延迟是常见的,有23%的患者接受了不正确的初始诊断.
- 获得专门的肉瘤服务和多学科团队仍然是一个挑战,有13%的患者从未见过专家.
研究的目的:
- 增强对软组织肉瘤患者的诊断和治疗过程的理解.
- 突出诊断罕见癌症的挑战和专业护理的重要性.
- 讨论肉瘤对患者生活的多方面的影响以及医疗保健专业人员的作用.
主要方法:
- 一个播客,一个软组织肉瘤患者和一个专门的肉瘤护士.
- 讨论患者从初始诊断到治疗和康复的旅程.
- 探索肉瘤对生理,情绪和精神的影响.
主要成果:
- 播客旨在为听众提供关于诊断软组织肉瘤的困难的见解.
- 它将涵盖可用的诊断工具以及清晰的患者沟通的重要性.
- 强调了癌症护士专家和患者支持小组的关键作用.
结论:
- 改善软组织肉瘤的诊断和管理需要解决早期识别和获得专业护理的挑战.
- 患者和护士的观点为肉瘤经历提供了宝贵的见解.
- 有效的沟通和多学科的支持对于最佳的患者结果至关重要.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


